Drugs / prenoxdiazine
prenoxdiazine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03837938 Comparator | Nov 2016 → Mar 2018 | — | Dompé Farmaceutici S.p.A | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | prenoxdiazine | “Libexin® (prenoxdiazine) 100 mg tablets. Libexin® was administered orally, 1 tablet (100 mg) 3 times a day for 7 days.” NCT03837938 ↗ |
| Known as | Libexin | “Libexin® (prenoxdiazine) 100 mg tablets. Libexin® was administered orally, 1 tablet (100 mg) 3 times a day for 7 days.” NCT03837938 ↗ |
| Known as | Prenoxdiazin | ChEMBL registry synonym — accepted as the source's own label CHEMBL2105302 ↗ |
| Known as | Prenoxdiazina | ChEMBL registry synonym — accepted as the source's own label CHEMBL2105302 ↗ |
| Modality | Small molecule | — CHEMBL2105302 ↗ |
| Route | Oral | “Libexin® was administered orally” NCT03837938 ↗ |